Hetero and Dr Reddy’s — will be funded by the Gates Foundation and Unitaid, respectively, to produce and sell the twice-a-year anti-HIV shot, lenacapavir, for $40 (around R692) per person per ...

Lenacapavir is a long-acting injectable antiretroviral drug developed by Gilead Sciences. It is administered just twice a ...

ORLANDO, Fla. — As the Trump administration works to slim down government spending, that includes millions of dollars in funding for HIV medications. LGBT+ Center Orlando was established in 1978. The ...

Let's say you fall in love with someone harboring a deadly -- and highly infectious -- virus. And you think … is it crazy to get married? Sometimes love conquers all — with the help of modern medicine ...

In April 2025, we published a story with the headline: "Haunted by hopelessness: 12 Zambians share their stories as HIV drugs run out." It looked at the impact of President Trump's cuts to foreign aid ...

AS ERICA FISHER’S nuptials approach, she’s trying to decide: Should she take a beta blocker before she walks down the aisle? Everyone seems to be talking about the drugs, she says—from her favorite ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. Hello there from STAT reporter Andrew Joseph, filling in for Mr.

NKULAGIRIRE, Uganda (AP) — Past a smoldering pile of trash and two bleating goats, through a doorway beginning to buckle beneath the weight of the bricks above, is a darkened room where a skeletal, 70 ...

When President Donald Trump began his second term, the world was on the verge of a miracle: ending the global HIV pandemic by 2030. With the first strokes of his pen, Trump set to erase decades of ...

A new pre-exposure prophylaxis (PrEP) drug has shown promise as a once-monthly oral pill to help prevent HIV. PrEP plays a key part in reducing the number of new HIV infections by stopping the virus ...

A new HIV antiretroviral shows promise as a long-acting, oral prophylactic agent, according to a new study by Izzat Raheem, Tracy Diamond and colleagues from Merck & Co., Inc., Rahway, NJ, U.S., ...